Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Submitted by
admin
on July 10, 2013 - 11:05am
Source:
Yahoo/AP
News Tags:
JNJ
Pharmacyclics
ibrutinib
chronic lymphocytic leukemia
Headline:
Pharmacyclics and Johnson & Johnson submit blood cancer drug ibrutinib to FDA for approval
Do Not Allow Advertisers to Use My Personal information
